RSNA 2009 

Abstract Archives of the RSNA, 2009


VI51-04

Stent Graft Placement in Aortic Arch Pathologies Treated with or without a Debranching Procedure: Results from the RESTORE Registry

Scientific Papers

Presented on December 3, 2009
Presented as part of VI51: Interventional Radiology Series: Aortic and Peripheral Aneurysms Imaging and Interventions

Participants

Dominik Berzaczy MD, Presenter: Nothing to Disclose
Gundula Edelhauser, Abstract Co-Author: Nothing to Disclose
Melanie B. Schernthaner MD, Abstract Co-Author: Nothing to Disclose
Martin Popovic, Abstract Co-Author: Nothing to Disclose
Martin Czerny, Abstract Co-Author: Nothing to Disclose
Johannes Lammer MD, Abstract Co-Author: Research Consultant, W. L. Gore & Associates, Inc Investigator, Abbott Laboratories
Martin A. Funovics MD, Abstract Co-Author: Nothing to Disclose

PURPOSE

To compare efficacy, safety, and short-term follow-up of thoracic endovascular aortic repair (TEVAR) with a newly designed stentgraft in patient subgroups with and without metachroneous aortic rerouting procedures.

METHOD AND MATERIALS

Basis of the analysis is a prospective European multicenter monitored clinical registry (RESTORE) of patients treated with acute or elective TEVAR with the Relay stentgraft (Bolton Medical, Sunrise, FL, USA). Patients were assigned to one of two groups without (n=115) or with (n=80) a debranching procedure before stentgraft placement. Debranching procedures included: left subclavian transposition (n=47); subclavian and left carotid transposition (n=21); triple rerouting (n=12). For each group, endpoints were: technical success, complication rate, occurrence of endoleaks and mortality.

RESULTS

For the groups without and with debranching procedures, respectively, technical success was 98.3% and 97.5% (p=1.00). Complication rates were 19.1% and 16.3% (p= .71). Early endoleaks (within 30 days) occurred in 5.8% and 6.3% (p=1.0). Late endoleaks occurred in 8.2% and 11.1% (p= .58). Overall mortality was 11.3% and 11.7% (p= .77).

CONCLUSION

In the RESTORE dataset, no significant differences and, more importantly, similar outcome can be observed in the patient groups without and with supraaortic debranching procedures before TEVAR with the Relay stentgraft. The data support the hypothesis that debranching procedures are a safe option to extend TEVAR treatment into the aortic arch.

CLINICAL RELEVANCE/APPLICATION

 

Cite This Abstract

Berzaczy, D, Edelhauser, G, Schernthaner, M, Popovic, M, Czerny, M, Lammer, J, Funovics, M, Stent Graft Placement in Aortic Arch Pathologies Treated with or without a Debranching Procedure: Results from the RESTORE Registry.  Radiological Society of North America 2009 Scientific Assembly and Annual Meeting, November 29 - December 4, 2009 ,Chicago IL. http://archive.rsna.org/2009/8008857.html